Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 9795269, 10 pages
http://dx.doi.org/10.1155/2016/9795269
Review Article

Clinically Meaningful Use of Blood Tumor Markers in Oncology

1University of Bonn, Bonn, Germany
2Mayo Clinic, Department of Oncology, Division of Medical Oncology, Rochester, MN, USA
3Roche Diagnostics, Indianapolis, USA
4Roche Diagnostics International, Rotkreuz, Switzerland

Received 20 April 2016; Accepted 17 October 2016

Academic Editor: Franco M. Buonaguro

Copyright © 2016 Stefan Holdenrieder et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Stefan Holdenrieder, Lance Pagliaro, David Morgenstern, and Farshid Dayyani, “Clinically Meaningful Use of Blood Tumor Markers in Oncology,” BioMed Research International, vol. 2016, Article ID 9795269, 10 pages, 2016. https://doi.org/10.1155/2016/9795269.